Andrew John Oakley

Andrew John Oakley is a declared insider of Onconetix, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 23 March 2025 and the latest from 15 August 2025.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 19 August 2025 came the latest disclosure, a share grant in Onconetix, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.